CareDx (CDNA) Tops Q1 EPS by 28c ; Offers Guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of $0.09, $0.28 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $84.7 million versus the consensus estimate of $84.37 million.

GUIDANCE:

CareDx sees FY2025 revenue of $365-375 million, versus the consensus of $370.9 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Goldman Sachs Reiterates Conviction Buy Rating on Golar LNG Ltd. (GLNG)
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge
• Asana (ASAN) Reiterated at Market Outperform by Citizens Post Investor Meet